Only a minority of studies, that is, four in Parkinsons disease 52,53,54,55 , five in substance-use disorders 111,113,115,116,117 , one in psychotic disorders 144 and two in mood disorders 178,179,182 , assessed the cognitive and mental health effects of GLP-1RAs in non-diabetic, non-obese populations
Nothing here is medical, dosing, or therapeutic guidance
This deficiency may contribute to the oxidative stress and inflammation commonly observed in lupus patients
125 NakanishiH.SunY.NakamuraR
Expect new warning letters to compounders and telehealth clinics citing Import Alert 66-80 as context
Future clinical studies need to be larger in scale in order to refute or confirm what earlier studies have found